Latest AstraZeneca Pharma stock price
AstraZeneca Pharma P/E Ratio
ASTRAZEN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
105.39
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
105.39
Current Price
₹8418.50
EPS (TTM)
₹46.30
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
56.78
Sector Median
35.38
Sector Rank
#11 of 88
Sector Percentile
12.5%
Key P/E Ratio Insights for AstraZeneca Pharma
- Stock appears overvalued with PE of 105.39, suggesting caution for new investments
- Trading at premium to sector average PE of 56.78
View the ASTRAZEN equity price for detailed stock performance.
Related Pages for AstraZeneca Pharma
Additional stock information and data for ASTRAZEN
Sector P/E Ratio Comparison
Comparing AstraZeneca Pharma with other companies in Healthcare sector
Sector Average
56.78
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |